Skip to main content

Antisense Methods in Cell Culture

  • Chapter
Animal Cell Culture Techniques

Part of the book series: Springer Lab Manual ((SLM))

  • 1454 Accesses

Abstract

The notion of using specific oligonucleotides for the modulation of gene expression surfaced nearly two decades ago when DNA oligonucleotides were used to inhibit Rous sarcoma virus replication and cell transformation (Zamenick 1978). The basic idea behind the use of antisense molecules is quite simple. An oligonucleotide chain containing bases complementary to a given target (sense) sequence can bind to this target sequence, and thus inhibit its processing, through the interactions defined by the Watson and Crick base pairing rules. These rules state that a guanosine must always base pair with a cytosine, while a tyrosine must base pair with an adenosine. Thus, once the sequence of a target gene is known, an antisense molecule can be designed which specifically binds to this gene alone. The initial antisense molecules were oligodeoxynucleotide sequences targeted to mRNA molecules. However, recent advances in molecular biology have widened the spectrum of antisense compounds to include RNA oligos targeted against RNA, DNA oligos targeted against DNA (termed antigenes) and either DNA or RNA oligos which bind to and inhibit the function of peptides and proteins (termed aptamers) (for reviews see Ma and Calvo 1996; Scanlon et al. 1995; Wagner 1994, 1995; Zhang 1996).

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 119.00
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD 159.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  • Askari F, McDonnell W (1996) Antisense-oligonucleotide therapy. New Eng J Med 334:316–318

    Article  PubMed  CAS  Google Scholar 

  • Bennett C, Dean N, Ecker D, Monia B (1995) Pharmacology of antisense therapeutic agents. In: Agrawal S (ed) Methods in molecular medicine: antisense therapeutics. Human,Totowa, New Jersey, pp 13–46

    Google Scholar 

  • Bergan R, Connell Y, Fahmy B, Neckers L (1993) Electroporation enhances c-myc antisense oligonucleotide efficacy. Nucleic Acids Res 21(15):3567–3573

    Article  PubMed  CAS  Google Scholar 

  • Bergan R, Graham M, Crooke M, Crooke S (1995) In vitro pharmokinetics of phosphorothioate antisense oligonucleotides. J Pharmacol Exp Ther 275:462–473

    Google Scholar 

  • Crooke R, Graham M, Crooke M, Crooke S (1995) In vitro pharmokinetics of phosphorothioate antisense oligonucleotides. J Pharmacol Exp Ther 275:462–473

    PubMed  CAS  Google Scholar 

  • Editorial (1994) Problems in interpretation of data derived from in vitro and in vivo use of antisense oligodeoxynucleotides. Antisense Res Dev 4:67–69

    Google Scholar 

  • Editorial (1995) Delivery of oligonucleotides and polynucleotides. J Drug Target 3:185–190

    Article  Google Scholar 

  • Gerwitz A, Stein C, Glazer P (1996) Facilitating oligonucleotide delivery: helping antisense deliver on its promise. Proc Natl Acad Sci USA 93:3161–3163

    Article  Google Scholar 

  • Ma L, Calvo F (1996) Recent status of the antisense oligonucleotide approaches in oncology. Fundam Clin Pharmacol 10:97–115

    Article  PubMed  Google Scholar 

  • Scanlon K, Ohta Y, Ishida H, Kijma H, Ohkawa T, Kaminski A, Tsai J, Horng G, Kashani-Sabet M (1995) Oligonucleotide-mediated modulation of mammalian gene expression. FASEB J 9:1288–1296

    PubMed  CAS  Google Scholar 

  • Sharma H, Narayanan R (1995) The therapeutic potential of antisense oligonucleoti-des. BioEssays 17(12):1055–1063

    Article  PubMed  CAS  Google Scholar 

  • Skotzko M, Wu L, Anderson W, Gordon E, Hall F (1995) Retroviral Vector-mediated gene transfer of antisense cyclin Gl (CYCG1) inhibits proliferation of human oste-ogenic sarcoma cells. Cancer Res 55:5493–5498

    PubMed  CAS  Google Scholar 

  • Stein C (1995) Does antisense exist. Nature Med 11:1119–1121

    Google Scholar 

  • Wagner R (1994) Gene inhibition using antisense oligodeoxynucleotides. Nature 372:333–335

    Article  PubMed  CAS  Google Scholar 

  • Wagner R (1995) The state of the art in antisense research. Nature Med 11:1116–1118

    Article  Google Scholar 

  • Zamecnik P, Stephenson M (1978) Inhibition of Rous sarcoma virus replication and cell transformation by a sepcific oligodeoxynucleotide. Proc Natl Acad Sci USA 75: 1:280–284

    Article  PubMed  CAS  Google Scholar 

  • Zhang W (1996) Antisense oncogene and tumor suppressor gene therapy of cancer. J Mol Med 74:191–204

    Article  PubMed  CAS  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Daragh Byrne .

Editor information

Editors and Affiliations

Rights and permissions

Reprints and permissions

Copyright information

© 1998 Springer-Verlag Berlin Heidelberg

About this chapter

Cite this chapter

Byrne, D., Daly, C., Clynes, M. (1998). Antisense Methods in Cell Culture. In: Clynes, M. (eds) Animal Cell Culture Techniques. Springer Lab Manual. Springer, Berlin, Heidelberg. https://doi.org/10.1007/978-3-642-80412-0_29

Download citation

  • DOI: https://doi.org/10.1007/978-3-642-80412-0_29

  • Publisher Name: Springer, Berlin, Heidelberg

  • Print ISBN: 978-3-540-63008-1

  • Online ISBN: 978-3-642-80412-0

  • eBook Packages: Springer Book Archive

Publish with us

Policies and ethics